Butterfly Network’s Embedded™ Partner Aleph Neuro Unveils Stunning Brain Images

Key Terms

brain-computer interface medical

A brain-computer interface is a device or system that reads electrical signals from the brain and translates them into commands a computer or machine can understand, like a translator turning thoughts into actions. For investors, it matters because these technologies can create new markets in healthcare, assistive devices and consumer electronics, but they also carry high development costs, regulatory hurdles and uncertain adoption timelines that affect potential returns and risk.

ultrasound-on-chip technical

Ultrasound-on-chip packs the components that generate and detect ultrasound waves onto a tiny semiconductor chip, shrinking a traditional ultrasound device into a compact, lower-cost electronic module. Like turning a bulky camera into a smartphone lens, it can enable portable, more affordable medical scanners and consumer health gadgets, creating new revenue opportunities and faster manufacturing scale — though commercial value depends on clinical acceptance and regulatory clearance.

restricted stock units financial

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

class b common stock financial

A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.

broker non-votes regulatory

Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Brain-computer interface research lab building on Butterfly's Ultrasound-on-Chip™ platform achieves what it deems a breakthrough in non-invasive neuroimaging, with implications for how humans may one day communicate and connect.

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)-- Butterfly Network, Inc. ("Butterfly") (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today responded to Aleph Neuro (Aleph)'s public launch and announcement of what it describes as a breakthrough in non-invasive brain imaging using ultrasound. Aleph is a participant in the Butterfly Embedded™ licensing and co-development program powering a new wave of ultrasound-enabled technologies.

Aleph is a research lab building brain interfaces for the telepathic future. The lab today announced on X that it has captured what it describes as the highest-resolution 3D images of the human brain taken from outside of the skull: (https://x.com/alephneuro/status/2070183632132845995). In the post, Aleph explained its approach as delivering "MRI-level detail of the brain" without drilling or the bulk of an MRI machine — addressing what it sees as the two fundamental hardware bottlenecks in the field. Information about Aleph can be found on their website: https://alephneuro.com/, with more details on the technical blog: https://alephneuro.com/blog/ultrasound-brain

"Researchers like Aleph Neuro are using Butterfly's Ultrasound-on-Chip™ to reimagine the capabilities of ultrasound and challenge the status quo," said Joseph DeVivo, President, Chief Executive Officer and Chairman of Butterfly Network. "I encourage everyone to go to AlephNeuro.com to see what this exciting new lab is venturing to do. We congratulate the Aleph team on their progress."

Aleph's announcement follows last week's full-body ultrasound CT scanner unveiling from another Butterfly Embedded™ partner, Midjourney. Together, these milestones underscore the expanding impact of Ultrasound-on-Chip™ across the future of health and technology.

About Butterfly Network

Butterfly Network, Inc. (NYSE: BFLY) is driving a digital revolution in ultrasound imaging and sensing with its proprietary Ultrasound-on-Chip™ semiconductor technology and software solutions. Butterfly first proved its technology in the point-of-care ultrasound market – commercializing the world's first single-probe, whole-body portable ultrasound device, which is now on its best-selling, third-generation: Butterfly iQ3™. The Company combines its advanced hardware with cloud software and AI, an enterprise workflow solution (Compass AI™) and other offerings to drive adoption of affordable, accessible ultrasound. Butterfly also enables third-party development of imaging AI apps through Butterfly Garden™, its software development kit and AI marketplace.

In addition to its medical imaging products, Butterfly Embedded™ is the Company's Ultrasound-on-Chip™ licensing and co-development business designed to enable a new wave of ultrasound-enabled technologies across non-competitive healthcare markets and beyond. Through Butterfly Embedded™, partners can build and scale novel ultrasound applications powered by Butterfly's proprietary semiconductor chip and software platform.

Butterfly's innovations have been recognized by Prix Galien USA, Fierce 50, TIME's Best Inventions and Fast Company's World Changing Ideas, among other achievements. To learn more, visit: www.butterflynetwork.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20260625817511/en/

Media:
Andrea Heuer
AOx3 for Butterfly
andrea@12080group.com
917-914-5563

Investors:
John Doherty
Chief Financial Officer
investors@butterflynetinc.com

Source: Butterfly Network, Inc.